Latest / The Claire Byrne Show
A personalized vaccine for skin cancer shows promise at clinical trial stage
A personalized vaccine for skin cancer could cut the risk of it returning after five years. To explain this further with Claire was Orla Dolan, CEO of Breakthrough Cancer Research.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.